Mydecine – Medicine Evolved
Mydecine Innovations Group™ is a biotechnology company developing first- and second-generation novel therapeutics to treat mental health and addiction disorders. Using world-class technology and drug development infrastructure, we are advancing new treatment options in areas of significant unmet need. Our global team is progressing a robust research and development pipeline of psychedelic and non-psychedelic therapeutics, novel compounds and controlled drug delivery systems.
Publicly traded on: (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA)Learn About Mydecine